Survival and Estimation of Direct Medical Costs of Hospitalized COVID-19 Patients in the Kingdom of Saudi Arabia

Overview

Journal Int J Environ Res Public Health

Publisher MDPI

Specialties Environmental Health
Public Health

Date 2020 Oct 17

PMID 33066327

Citations 42

Authors

Anas A Khan

Yazed AlRuthia

Bander Balkhi

Sultan M Alghadeer

Mohamad-Hani Temsah

Saqer M Althunayyan

Yousef M Alsofayan

Affiliations

Soon will be listed here.

Abstract

Objectives: Assess the survival of hospitalized coronavirus disease 2019 (COVID-19) patients across age groups, sex, use of mechanical ventilators (MVs), nationality, and intensive care unit (ICU) admission in the Kingdom of Saudi Arabia.

Methods: Data were retrieved from the Saudi Ministry of Health (MoH) between 1 March and 29 May 2020. Kaplan-Meier (KM) analyses and multiple Cox proportional-hazards regression were conducted to assess the survival of hospitalized COVID-19 patients from hospital admission to discharge (censored) or death. Micro-costing was used to estimate the direct medical costs associated with hospitalization per patient.

Results: The number of included patients with complete status (discharge or death) was 1422. The overall 14-day survival was 0.699 (95%CI: 0.652-0.741). Older adults (>70 years) (HR = 5.00, 95%CI = 2.83-8.91), patients on MVs (5.39, 3.83-7.64), non-Saudi patients (1.37, 1.01-1.89), and ICU admission (2.09, 1.49-2.93) were associated with a high risk of mortality. The mean cost per patient (in SAR) for those admitted to the general Medical Ward (GMW) and ICU was 42,704.49 ± 29,811.25 and 79,418.30 ± 55,647.69, respectively.

Conclusion: The high hospitalization costs for COVID-19 patients represents a significant public health challenge. Efficient allocation of healthcare resources cannot be emphasized enough.

Citing Articles

The financial burden of SARS-CoV-2 pregnancies in a tertiary exclusive COVID-19 maternity.

Bobei T, Sima R, Gorecki G, Amza M, Bobirca A, Popescu M J Med Life. 2024; 17(5):471-477.

PMID: 39144686 PMC: 11320610. DOI: 10.25122/jml-2024-0128.

Assessment of Direct Medical Cost of Hospitalized COVID-19 Adult Patients in Kuwait During the First Wave of the Pandemic.

AlManie S, AlHazami M, Ebrahim A, Attique M Clinicoecon Outcomes Res. 2024; 16:509-522.

PMID: 39069972 PMC: 11283802. DOI: 10.2147/CEOR.S467543.

Economic burden due to COVID-19 in a Colombian Caribbean state, 2020 and 2021.

Salcedo-Mejia F, Moyano-Tamara L, Zakzuk J, Lozano A, Serrano-Coll H, Gastelbondo B Epidemiol Serv Saude. 2024; 33:e2023830.

PMID: 38985065 PMC: 11251452. DOI: 10.1590/S2237-96222024V33E2023830.EN.

The Economic Burden of the COVID-19 Pandemic in State of Kuwait.

Nur A, Aljunid S, Almari M Clinicoecon Outcomes Res. 2024; 16:111-122.

PMID: 38463550 PMC: 10921943. DOI: 10.2147/CEOR.S442913.

The global economic burden of COVID-19 disease: a comprehensive systematic review and meta-analysis.

Faramarzi A, Norouzi S, Dehdarirad H, Aghlmand S, Yusefzadeh H, Javan-Noughabi J Syst Rev. 2024; 13(1):68.

PMID: 38365735 PMC: 10870589. DOI: 10.1186/s13643-024-02476-6.

References

Bartsch S, Ferguson M, McKinnell J, OShea K, Wedlock P, Siegmund S . The Potential Health Care Costs And Resource Use Associated With COVID-19 In The United States. Health Aff (Millwood). 2020; 39(6):927-935. PMC: 11027994. DOI: 10.1377/hlthaff.2020.00426. View

Ferroni E, Rossi P, Spila Alegiani S, Trifiro G, Pitter G, Leoni O . Survival of Hospitalized COVID-19 Patients in Northern Italy: A Population-Based Cohort Study by the ITA-COVID-19 Network. Clin Epidemiol. 2020; 12:1337-1346. PMC: 7737545. DOI: 10.2147/CLEP.S271763. View

Wenham C, Smith J, Morgan R . COVID-19: the gendered impacts of the outbreak. Lancet. 2020; 395(10227):846-848. PMC: 7124625. DOI: 10.1016/S0140-6736(20)30526-2. View

Verity R, Okell L, Dorigatti I, Winskill P, Whittaker C, Imai N . Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis. 2020; 20(6):669-677. PMC: 7158570. DOI: 10.1016/S1473-3099(20)30243-7. View

Dong E, Du H, Gardner L . An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020; 20(5):533-534. PMC: 7159018. DOI: 10.1016/S1473-3099(20)30120-1. View

Mi Y, Huang T, Zhang J, Qin Q, Gong Y, Liu S . Estimating the instant case fatality rate of COVID-19 in China. Int J Infect Dis. 2020; 97:1-6. PMC: 7180353. DOI: 10.1016/j.ijid.2020.04.055. View

Onder G, Rezza G, Brusaferro S . Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA. 2020; 323(18):1775-1776. DOI: 10.1001/jama.2020.4683. View

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223):497-506. PMC: 7159299. DOI: 10.1016/S0140-6736(20)30183-5. View

Auld S, Caridi-Scheible M, Blum J, Robichaux C, Kraft C, Jacob J . ICU and Ventilator Mortality Among Critically Ill Adults With Coronavirus Disease 2019. Crit Care Med. 2020; 48(9):e799-e804. PMC: 7255393. DOI: 10.1097/CCM.0000000000004457. View

10.

Wang Q, Shi N, Huang J, Yang L, Cui T, Ai J . Cost-Effectiveness of Public Health Measures to Control COVID-19 in China: A Microsimulation Modeling Study. Front Public Health. 2022; 9:726690. PMC: 8763804. DOI: 10.3389/fpubh.2021.726690. View

11.

Khafaie M, Rahim F . Cross-Country Comparison of Case Fatality Rates of COVID-19/SARS-COV-2. Osong Public Health Res Perspect. 2020; 11(2):74-80. PMC: 7104689. DOI: 10.24171/j.phrp.2020.11.2.03. View

12.

Ludvigsson J . Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr. 2020; 109(6):1088-1095. PMC: 7228328. DOI: 10.1111/apa.15270. View

13.

Richardson S, Hirsch J, Narasimhan M, Crawford J, McGinn T, Davidson K . Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020; 323(20):2052-2059. PMC: 7177629. DOI: 10.1001/jama.2020.6775. View

14.

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229):1054-1062. PMC: 7270627. DOI: 10.1016/S0140-6736(20)30566-3. View

15.

Tian W, Jiang W, Yao J, Nicholson C, Li R, Sigurslid H . Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis. J Med Virol. 2020; 92(10):1875-1883. PMC: 7280666. DOI: 10.1002/jmv.26050. View

16.

Nicola M, Alsafi Z, Sohrabi C, Kerwan A, Al-Jabir A, Iosifidis C . The socio-economic implications of the coronavirus pandemic (COVID-19): A review. Int J Surg. 2020; 78:185-193. PMC: 7162753. DOI: 10.1016/j.ijsu.2020.04.018. View

17.

Giangreco G . Case fatality rate analysis of Italian COVID-19 outbreak. J Med Virol. 2020; 92(7):919-923. PMC: 7262321. DOI: 10.1002/jmv.25894. View

18.

Alsofayan Y, Althunayyan S, Khan A, Hakawi A, Assiri A . Clinical characteristics of COVID-19 in Saudi Arabia: A national retrospective study. J Infect Public Health. 2020; 13(7):920-925. PMC: 7833063. DOI: 10.1016/j.jiph.2020.05.026. View

19.

Sjodin H, Johansson A, Brannstrom A, Farooq Z, Kriit H, Wilder-Smith A . COVID-19 healthcare demand and mortality in Sweden in response to non-pharmaceutical mitigation and suppression scenarios. Int J Epidemiol. 2020; 49(5):1443-1453. PMC: 7543571. DOI: 10.1093/ije/dyaa121. View

20.

Salje H, Tran Kiem C, Lefrancq N, Courtejoie N, Bosetti P, Paireau J . Estimating the burden of SARS-CoV-2 in France. Science. 2020; 369(6500):208-211. PMC: 7223792. DOI: 10.1126/science.abc3517. View